Human rabies immunoglobulin

Active ingredient description

Human rabies immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against rabies virus. Human Rabies Immunoglobulin must always be used in combination with a rabies vaccine.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
J06BB05 Rabies immunoglobulin J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins
Discover more medicines within J06BB05

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
HUMAN RABIES IMMUNOGLOBULIN Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
HYPERRAB Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

External identifiers

DrugBank Drug: DB11603
RxNorm Ingredient: 89886
UNII Identifier: 95F619ATQ2
HUMAN RABIES VIRUS IMMUNE GLOBULIN

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.